ACE gene variants rise the risk of severe COVID-19 in patients with hypertension, dyslipidemia or diabetes. A pilot study
María Íñiguez, Patricia Pérez-Matute, Pablo Villoslada-Blanco, Emma Recio-Fernandez, Diana Ezquerro-Pérez, Jorge Alba, M. Lourdes Ferreira-Laso, José A. Oteo
doi: https://doi.org/10.1101/2021.03.24.21253576
María Íñiguez
1Infectious Diseases, Microbiota and Metabolism Unit, Infectious Diseases Department, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain
Patricia Pérez-Matute
1Infectious Diseases, Microbiota and Metabolism Unit, Infectious Diseases Department, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain
Pablo Villoslada-Blanco
1Infectious Diseases, Microbiota and Metabolism Unit, Infectious Diseases Department, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain
Emma Recio-Fernandez
1Infectious Diseases, Microbiota and Metabolism Unit, Infectious Diseases Department, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain
Diana Ezquerro-Pérez
2Infectious Diseases Department. Hospital Universitario San Pedro, Logroño, Spain
Jorge Alba
2Infectious Diseases Department. Hospital Universitario San Pedro, Logroño, Spain
M. Lourdes Ferreira-Laso
3Department of Anesthesiology and Postoperative Care, Hospital Universitario San Pedro, Logroño, Spain
José A. Oteo
4Infectious Diseases, Microbiota and Metabolism Unit, Infectious Diseases Department, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain; Infectious Diseases Department, Hospital Universitario San Pedro, Logroño, Spain
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Posted March 26, 2021.
ACE gene variants rise the risk of severe COVID-19 in patients with hypertension, dyslipidemia or diabetes. A pilot study
María Íñiguez, Patricia Pérez-Matute, Pablo Villoslada-Blanco, Emma Recio-Fernandez, Diana Ezquerro-Pérez, Jorge Alba, M. Lourdes Ferreira-Laso, José A. Oteo
medRxiv 2021.03.24.21253576; doi: https://doi.org/10.1101/2021.03.24.21253576
ACE gene variants rise the risk of severe COVID-19 in patients with hypertension, dyslipidemia or diabetes. A pilot study
María Íñiguez, Patricia Pérez-Matute, Pablo Villoslada-Blanco, Emma Recio-Fernandez, Diana Ezquerro-Pérez, Jorge Alba, M. Lourdes Ferreira-Laso, José A. Oteo
medRxiv 2021.03.24.21253576; doi: https://doi.org/10.1101/2021.03.24.21253576
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4287)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2767)
- Health Policy (1025)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4063)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6667)
- Radiology and Imaging (1456)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)